These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. The complexity of virus systems: the case of endosymbionts. Metcalf JA; Bordenstein SR Curr Opin Microbiol; 2012 Aug; 15(4):546-52. PubMed ID: 22609369 [TBL] [Abstract][Full Text] [Related]
69. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems. Moynihan PJ; Clarke AJ Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603 [TBL] [Abstract][Full Text] [Related]
70. The membrane action mechanism of analogs of the antimicrobial peptide Buforin 2. Hao G; Shi YH; Tang YL; Le GW Peptides; 2009 Aug; 30(8):1421-7. PubMed ID: 19467281 [TBL] [Abstract][Full Text] [Related]
71. The PECACE domain: a new family of enzymes with potential peptidoglycan cleavage activity in Gram-positive bacteria. Pagliero E; Dideberg O; Vernet T; Di Guilmi AM BMC Genomics; 2005 Feb; 6():19. PubMed ID: 15717932 [TBL] [Abstract][Full Text] [Related]
72. Fusion to cell-penetrating peptides will enable lytic enzymes to kill intracellular bacteria. Borysowski J; Górski A Med Hypotheses; 2010 Jan; 74(1):164-6. PubMed ID: 19656633 [TBL] [Abstract][Full Text] [Related]
73. Antimicrobial peptides: new candidates in the fight against bacterial infections. Toke O Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793 [TBL] [Abstract][Full Text] [Related]